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A synthesis is described for a number of 16,16-
dimethyl analogs of the prostacyclin and related 6-keto
prostaglandin types. Included are l6,l6-dimethyl-PGIO
sodium salt (XLIV), 6c~-l6,l6-dimethyl-P~I1 (XLV),
6s-l6,l6-dimethyl-P~I~ (XLVII), 6-keto-l6,l6-dimethyl-
PGF1-~ (XLIX), and 6-keto-l6,l6-dimethyl PGE1 (LV).
Done, but not included, is the activity for these analogs
in the blood platelet aggregation inhibition assay. This
activity was consistently less than for the corresponding
16, 16-dihydro compounds.
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Prostaglandins are hormone-like substances that are
ubiquitous in human and animal tissues and are characterized
by a highly potent and diverse spectrum of biological
activities. Of the fourteen prostaglandins, thirteen occur
in man, with the highest concentration in human seminal fluid.
In tiny amounts, they have also been found in some non-m~’~~~
han tissues such as frog’s skin and spinal cord and recently
in coral.
These compounds are twenty carbon carboxylic acids
synthesized from certain polyunsaturated fatty acids by the
formation of a five-membered ring and the incorporation of
three oxygen atoms at certain positions. These positions
divide prostaglandins into the four main categories E,F,A,
and B, with the first three seeming to be the most important
therapeutically. All four groups have a trans double bond
at the 13 position and a hydroxyl group at C-15 in conmon.
The difference between the aforementioned prostaglandins
are that the E and F series possess an additional hydroxyl
group at C-ll and are distinguished from each other by the
presence of a carbonyl function at C-9 in the E series and
a C-9 hydroxyl in the F series. The A and B series may be
regarded as dehydration products of the E compounds whereby
loss of water has occurred with removal of the C-ll hydroxyl
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and formation of a double bond in the ring. This dehydration
is readily effected chemically and it is considered that some
of the A prostaglandins derived from natural sources are in
reality artifacts obtained from the E prostaglandins during
the isolation procedure.1
Some important prostaglandins are represented in the
following scheme (Scheme I) by diagrams of their molecular
structure. In general, all the prostaglandins are variants
of a basic 20-carbon carboxylic (COOT-I-bearing) fatty acid
incorporating a five-member cyclopentane ring. Slight struc
tural changes are responsible for quite distinct biological
effects. Prostaglandins of the 1,2 and 3 series respectively
incorporate one, two and three double bonds. The molecules
designated P0E and P0F are called primary prostaglandins;
the PGE structures have an oxygen atom (0) attached to the
cyclopentane ring at carbon site 9, whereas the ~ struc
tures have a hydroxyl (OH) group at the same site. Dehy
dration of a P0E molecule leads to either a P0A or a PGB
compound.
The principal interest in the prostaglandins has
focused on their remarkable versatility and the wide range
of their effects. The effects themselves may be quite
specific: for example, one prostaglandin, P0E2 (IV), lowers
blood pressure, whereas a closely related member of the
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the effects of the prostaglandins are based on certain broad
powers: regulation of the activity of smooth muscles, of
secretion, or of blood flow.3
Of particular interest are the effects of prostaglandins
on the female reproductive system. It has been shown that an
intravenous injection of a very low dose of either P~E2 (IV)
or P~F2-alpha (V) stimulates contraction of the uterus. This
finding, together with the finding that prostaglandins are
present in the amniotic fluid and in the venous blood of
women during the contractions of labor, suggested that the
prostaglandins may play an important role in parturition.
The substances have been used to facilitate childbearing
labor in several thousand women.2 Further studies of the
most effective dosage and route of administration of the
drug, as well as evaluation in comparison with other methods
of inducing labor, may lay a basis for wide adoption of the
use of a prostaglandin for this purpose.
The possible use of prostaglandins as agents for abortion
and for inducing menstruation is also being investigated.
There is evidence that prostaglandins produce these effects
by some process more complex than the mere stimulation of
uterine contraction. One suggested explanation is that the
prostaglandin may induce regression of the corpus luteum, an
event that generally does not occur after an ovum is
fertilized.2 There seems to be a strong possibility that
prostaglandins or perhaps synthetic analogues may become
5
important agents in controlling population growth.
~s another illustration of their versatility, the
prostaglandins seem to hold promise for the prevention of
peptic ulcers. Experiments have shown that PGE1 (III) or
PGE2 (IV) can prevent peptic ulcers in dogs and prevent
gastric and duodenal ulcers in rats. It seems well
established that ulceration of the stomach and the duodenum
is generally caused by prolonged exposure of their mucous
membrane to gastric juice of high acidity and peptic potency.
The stomach normally produces prostaglandins of the E series,
and these may serve to regulate gastric secretion under
normal circumstances and thus protect the stomach wall
against ulceration.2 If the studies on dogs and rats are
confirmed in man, the administration of B prostaglandins may
be a helpful treatment for ulcer patients who lack this
normal protection. Among other potential biological applica
tions are (1) Asthma: ~Thile they shut down gastric secretion,
prostaglandins seem to have a special talent for relaxing the
smooth muscles of the bronchial tubes and thus opening up the
air passages of the lungs. Unlike other bronchodilators,
prostaglandins seem to work just in the lungs. The short life
span prevents the spread of side effects and expecially
cardiovascular stimulation;3 (2) High Blood Pressure: Tests
have demonstrated that prostaglandin A can lower blood
pressure in patients with essential hypertension, apparently
by increasing the flow of urine and the excretion of sodium
6
ions;3 (3) Arthritis: Zurier and Quagliata of New York
University Medical Center have induced arthritis in a
group of rats and then treated some with PGE1 (1II).~
The untreated rats developed severe arthritis, while those
treated showed no symptoms at all. If nothing else, it is
clear that prostaglandins play a considerable role in the
inflrnnnation process;3 (4) Clearing the nasal passages:
Applied topically to the nose, PGE1 (III) has been found
effective in widening the passages by constricting the blood
vessels;2 (5) Regulating metabolism: PGE1 (III) has been
shown to counteract the effects of many hormones in stimu
lating the metabolic processes, for example, the breaking
down of lipids in fatty tissues.2
Recently some English scientists discovered that
prostaglandins acted as mediators in certain kinds of
inflstmn’ption and headache.3 It turns out that the action
of aspirin could be at least partly explained in terms of
the way aspirin blocked the synthesis of the prostaglandins
responsible. Still even more recently, researchers from the
University of California reported that prostaglandins
produced by certain bacteria on the teeth might be the
culprits behind periodontal disease.3 lihen administered as
a drug, a tiny dose of prostaglandin can either boost or
inhibit the body’s natural production of prostaglandin.
Much evidence now points strongly to the likelihood
that the prostaglandins play a fundamental and critical
7
role in the physiology of marranals. Production and release
of prostaglandins can be evoked by stimulation of nerves.
In recent experiments, testing preparations of the spleen of
the cat and the heart of the rabbit, it was found that
infusion of the prostaglandin E2 (IV) markedly inhibited
the release of norepinephrine by nerve stimulation.2
Prostaglandin formation has been noted in many other
apparently unrelated systems. For example, prostaglandins
are formed by the lungs during anaphylaxis, by the kidney
when its blood supply is restricted, by the surface of the
brain when peripheral sensory nerves are stimulated, by the
skin during human allergic contact eczema and during cercain
experimental inflammatory conditions. These diverse situations
suggest that prostaglandins may play a fundamental role not
only in normal physiological functions, but also in certain
pathological conditions
The prostaglandins are biosynthesized from certain
essential fatty acids by a microsomal enzyme system, prosta
glandin synthetase (PGBS), which is widely distributed in
mammalian tissues. They do not appear to be stored free in
tissues but instead are biosynthesized and released on
demand. For example, arachidonic acid (XV), the precursor
for PGE2 (IV) and PGF2-alpha (V), is stored in tissues as a
phospholipid and is liberated by activation of a phospholi
pase t~A” by a variety of physiological stimuli. The
hydrolyzed arachidonic acid (XV) serves as a substrate for
8
the P0BS and is converted to prostaglandins of the ttwoT~

























Once formed, the prostaglandins are rapidly inactivated
by enzymatic reactions which limit their sphere of
influence. The primary metabolic step is oxidation of
the C-l5 allylic hydroxyl by means of l5-hydroxy-
prostaglandin dehydrogenase, followed by reduction of
the 13,14-double bond by delta-13-prostaglandin reductase.
The major metabolic transformations in humans are outlined
in Scheme III.~
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In recent years, total chemical synthesis has assumed
major importance as a means of obtaining supplies of
prostaglandins and it is now the method of choice. Unlike
10
biosynthesis, it is not subject to the limitations imposed
by availability of an enzyme and it is capable of scale-up
to the production of substantial quantities of material.
Another advantage of total chemical synthesis is its
flexibility which enables the preparation of unnatural
stereoisomers and novel structural variants unobtainable by
any other means. Some of these have been prepared in an
attempt to overcome clinical shortcomings of the natural
forms such as their brief duration of action resulting from
rapid metabolic inactivation or the presence of side effects
as a consequence of their wide spectrum of biological activity.
Other novel synthetic forms have the advantage over the natural
compounds of greater ease of access owing to the possibility
of preparation by shorter synthetic procedures.
Prostacyclin is one of the most recently discovered
exciting members of the prostaglandin family. Called prosta
cyclin because it contains a second five-membered ring in
addition to the one common to all prostaglandins, the compound
was first discovered in late 1976 by Vane of Weilcome Research
Laboratories in the United Kingdom and his co-workers.7 As a
result of its very recent discovery, information on it is
very limited.
Prostacyclin is the most potent of the prostaglandins
yet discovered in inhibiting aggregation of blood platelets,
and it also dramatically dilates blood vessels. As potentially
important as prostacyclin is, both its study and its ultimate
:1:1
usefulness in medicine are limited by a very short biological
half-life of one or two minutes. Consequently, several
laboratories have been crying to develop more stable analogs
that retain the potency of the natural compound.
The work described in this thesis gives attention only
to the design of synthesis of the “primary” prostaglandins
F and E, and to the prostacyclin I. The starting point for
the synthesis is 16,16-dimethyl PGF1-alpha (I). It proceeds
through various types of functional groups and their placement
on the skeleton. The relative positioning of functional
groups is the key to understanding their interactions and the
design of synthesis.
EXPERIMENTAL
Nuclear magnetic resonance (NMR) spectra were recorded
on a Varian Associates A-60A spectrometer using deuterio
chloroform solutions. A Beckman IR 424 was used to record
spectra (neat) on potassium bromide plates. Removal of
solvents in vacuo refers to evaporation at aspirator
pressure on a rotary evaporator. Results of thin layer
chromatography were determined by spraying plates with a
sulfuric acid solution. Mass spectra were run with a Dupont
21-490 mass spectrometer.
Synthesis of 16,16-Dimethyl PGF2-c~ Methyl Ester (XLI).-
Diisopropylethylamine (2.5 ml) was added to a solution of
2.42g ( 6~3 m mol ). of l6,l6-dimethyl-P0F2-alpha (XL) in
50 ml of acetonitrile. After addition of 5 ml of methyl
iodide, the mixture was stirred at room temperature for 3
hr. The reaction mixture was checked for the presence of
starting material by thin layer chromatography (l00~
ethyl acetate). Upon determination of the completion of
the reaction, the mixture was concentrated to one-fourth of
its volume and diluted with 100 ml of ethyl acetate. The
solution was then washed with potassium hydrogen sulfate
solution (2x50 ml), once with brine, dried over magnesium
sulfate, and evaporated to yield l.78g of a yellowish oil.
The oily residue was dissolved in methylene chloride and
chromatographed over lOOg of silica gel, eluting with 50,
75, and l00~ ethyl acetate/skelly solvent B. From the 75~
12
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elutant, there was obtained l.73g (68~) of the methyl ester:
ir (GC14)3400 (OH), 1740 (ester, C=O), 1100 cm~ (methyl
ester); NMR (CDC13) c~3.7 (s, ester); mass spectrum
(m/e) 396 prominent peaks at 378, 360 (MT18, ~36),
Synthesis of 5-Iodo-6 R,S,-16,l6-Dimethyl P~I1 Methyl
Ester (XLII).--With stirring, a solution of l.82g (L~6 m
mol) of the methyl ester (XLI), 38 ml of methylene chloride
and 38 ml of saturated sodium carbonate solution was cooled
in an ice-water bath. After 10 mm, a solution of l.52g of
iodine in 95 ml of methylene chloride was added over a 15
mm period. The reaction was then allowed to progress for
1 hr. Completion of the reaction was determined by thin
layer chromatography (l007~ ethyl acetate). When no starting
material was detected, the organic phase was separated and
l0~ sodium bisulfate solution added until the layer decolor
ized. The organic phase was then washed with brine, dried
over magnesium sulfate, filtered and evaporated. The oily
residue was dissolved in methylene chloride and chromato
graphed over lOOg of silica gel eluting with 50, 75, and
lOOX ethyl acetate/skelly solvent B. Fractions of 50 ml
volume were collected. The product (2.40g, 99X) was
recovered from the 75-l00~ ethyl acetate fractions as a
yellow colored oil: ir (CC14) 3420 (OH), 1735 (ester, C=0),
1090 cm~ (methyl ester); NMR (CDC13) ~5.5 (multiplet),
~4.5 niultiplet, ~3.65 (singlet); mass spectrum (rn/c) 651,
other prominent peaks at 567 and 545; Anal; Calcd. for
1~4
C28E52Si205I: 65l,2~00, Found: (~CH3)
651.2383.
Synthesis of 16,16-Dimethyl ~ Methyl Ester (XLV).-
Tributyl tin chloride (2.5 ml) and 40 ml absolute ethanol,
under nitrogen, were added to a solution of 2.4 g
(406mmol) of the iodo ether. With continuous stirring, a
solution of O.5g of sodium borohydride in 20 ml absolute
ethanol was added over a 30 mm period. The reaction was
allowed to progress over a 2.5 hr period. It was followed
by thin layer chromatography on silica gel with 33~ ethyl
acetate/skelly solvent B and 50~ acetone/methylene chloride
as the developing agents. After acidifying with dilute
hydrochloric acid, the solution was concentrated to approxi
mately one-third its volume, diluted with 50 ml water and
extracted 3 times with 50 ml portions of ethyl acetate.
The combined extracts were washed once with brine, dried
over magnesium sulfate and evaporated. The residue was
purified by chromatography over lOOg silica gel. The column
was eluted with 500 ml of 33, 50, 75, and l00~ ethyl
acetate/skelly solvent B. Fractions of 50 ml volume were
collected. Fractions 3-11 (A) afforded l.68g of less polar
material related to the tributyl tin chloride reagent,
while fractions 16-27 (B) afforded l.Olg of the desired pro
duct. Thin layer chromatographic examination of the product
using 50:50 acetone/methylene chloride showed a heavy spotz
more polar than starting material together with a light,
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very slightly less polar spot. The latter is du~ to the
less polar 6-alpha isomer. The following data were
obtained for the mixed material: mass spectrum - weak
at 540, prominent ions at (rn/c) 509 and 450; ir (Cd4) 3400
(OH), 1740 (ester, C=O) , 1085 crn~- (methyl ester);
nmr (CDC13) a5~5 (m), 4,4 (m), 3~65 (m); tb
(l00~ ethyl acetate) Rf - 0.37. Anal: Calcd. for C28H53Si205:
525,3411. Found 525.3431,
Synthesis of 16,l6-Dirnethyl-P01] (XLVIII).--A solution
of the methyl ester (XLV) (0.75g, L9 m mol ), methanol
(10 ml) and 3N sodium hydroxide (2 ml) was stirred at room
temperature for 3 hr in a nitrogen atmosphere. Thin layer
chromatographic examination against starting material was
used to determine the completion of the reaction. The
reaction mixture was then concentrated under reduced pressure
to one-fourth its volume, poured over ice-water and acidified
with potassium hydrogen sulfate solution. The organic layer
was removed and the aqueous layer was extracted three times
with 20 ml portions of ethyl acetate. The combined organic
extracts were washed with brine, dried over magnesium sulfate
and evaporated (crude weight-0.2lg). The crude product
mixture was chromatographed over 50g acid-washed silica gel.
The column was eluted with 250 ml of 20:80 acetone/methylene
chloride, 250 ml of 30:70 acetone/methylene chloride, 500 ml
40:60 acetone/methylene chloride and 1 liter of 60:40
acetone/methylene chloride. Fractions of 50 ml volume were
J-o
collected. FrActions 25-28 afforded 140mg (20~ yield) of
the desired product: ir (CCI4) 3400 cm~ (OH) ; nmr (CDCI3)
~5.48-5.62 (m), 4.55 (m); tlc (A-IX)
Rf - 0.33. (The corresponding non-l6,16-dimethylated
material gave Rf - 0.25 on the same plate). Anal: Calcd.
for C30H59Si3O: 585.3670, Pound: (for ~CH3) 583.3656,
Synthesis of l6,16-Dimethyl-P012 Methyl Ester
(XLIII).--A solution of 3.3g ( 6.3 m mol) of the iodo
ether, 60 ml toulene, and 6.6 ml of diazabicyclo[4.3.O.]-
non-5-ene (DEN) was warmed at 450 for 24 hr. The reaction
was followed by thin layer chromatography on silica gel
with 1:1 acetone/hexane, A-IX, and ethyl acetate as
developers. Completion of the reaction was determined when
tlc showed no starting material remaining. The mixture was
then transferred to a separatory funnel and washed twice
with ice-water. The organic layers were combined and sta
bilized with triethylamine, dried over magnesium sulfate,
filtered and evaporated. A yellowish oil (2,47g) resulted.
Thin layer chromatography (ethyl acetate or acetone/hexane
1:1) showed a heavy spot slightly less polar than starting
material, a light spot a little more polar than starting
material probably due to the delta-4 isomer and a light spot
(unknown) less polar than product: ir (Ccl~) 3440 (OH),
1740 (ester, C0), 1105 cm~ (methyl ester); nmr (CDC13)
~5,53 (m), 4.67 (m), 4,32 (m), 3.67 (s); tlc (ethyl
acetate) Hf - 0,55 for product.
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Rf - 0.43 for PG-methyl ester on the same plate.
Synthesis of l6J6-Dimethyl-P~~ Sodium Salt (XLIV).-
A solution of 2.2g of methyl ester (XLIII), 50 ml methanol,
2.2g sodium bicarbonate and 25 ml water was stirred rapidly
at room temperature for 48 hr. An additional 24 hr was re
quired for completion of the reaction when thin layer
chromatography analysis (lOO~ ethyl acetate) determined that
a large amount of starting material remained. The reaction
mixture was filtered through charcoal and concentrated under
reduced pressure to remove methanol and then diluted with
25 ml of acetonitrile. Upon standing, a small watery layer
separated. The organic layer was separated and treated with
an additional 125 ml of acetonitrile to induce crystalliza
tion. This prodmced only a very small amount of a white
gummy material. Therefore, the mixture was concentrated to
an aqueous solution which was frozen and lyophilized to
afford l.68g as a hygroscopic white foam. A p-phenyl
phenacyl ester assay for the sodium salt was run as follows:
a few mgs of prostacyclin sodium salt was dissolved in
0.5 ml dirfiethyl formamide containing 5~ diisopropyl ethyl
amine and a few mgs of alpha-bromo ~-phenyl acetophenone
added. The mixture was swirled, then allowed to stand for
45 mm at room temperature. Saturated aqueous sodium bicar
bonate (0.5 ml) and ether (0.5 ml) were added to the mixture
and both were shaken. The upper ether layer was assayed by
thin layer chromatography using 75:25 ethyl acetate/skelly
solvent B as developing solvent. Spots were visualized by
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spraying with 5O~ sulfuric acid and heating on a hot plate
or viewing under uv light. This assay revealed a heavy
spot due to product and a light spot due to a small amount
of 6-keto contamination.
~ynthesis of 6-Keto-l6,l6-Dimethyl-P~F1-alpha (XLIX).--
A solution of the sodium salt (XILV)(lg, 2.43 m mol) in
25 ml water was acidified with 40 ml of dilute hydrochloric
acid (l0~). A cloudy solution resulted. Approximately 30
ml of ethyl acetate was added to the solution and the
resulting mixture was stirred at room temperature for 20 mm.
The organic layer was removed and the aqueous phase was
extracted with ethyl acetate (twice with 25 ml portions).
The combined organic extracts were washed with brine, dried
over magnesium sulfate and evaporated (crude weight-0.95g).
The crude product mixture was applied in methylene chloride
and chromatographed over 50g of acid-washed silica gel,
eluting with 250 ml of 40:60, 60:40, and 80:20 ethyl acetate/
skelly solvent B and 750 ml of l00~ ethyl acetate. Fractions
of 50 ml volume were collected. The product (O.76g, 77~ yield)
was obtained from several fractions: tlc (A-IX) RI - 0.23
(for product), 6-keto PGF1a (on the same plate) RI - 0.15;
Anal: Calcci. for C3~H7QSi4N06: 700.4280. Found:
Cfor M1CH3, TMS derivative) 700.4307.
Synthesis of p-Phenylphenacyl Ester of l6J6-Dimethyl
solution of the sodium salt XLIV (300mg 0.75
m mol) dimethyl formamide (DMF-3 ml) and p—phenylphenacyl
bromide (300 mg) was stirred at room temperature for
approximately 3 hr. To this reaction mixture was added
ice-water. The mixture was then rinsed in, and extracted
twice with ethyl acetate. Additional drops of triethyl
amine were added, and the mixture was washed in brine and
dried over magnesium sulfate. Evaporation of the solvent
in vacuo gave 302 mg of a golden oil. The crude product
was applied in methylene chloride and chrornatographed over
200g of Florisil prepared by slurry with 50:50 ethyl
acetate/skelly solvent B containing l~ triethyleneamine.
The column was eluted with 100 ml 50:50 ethyl acetate/
skelly solvent B and 0.25~ triethyleneamine and 200 ml of
75:25 ethyl acetate/skelly solvent B and 0.25~ triethylene
amine and l00~ ethyl acetate and 0.25~ triethyleneamine.
Fractions of 25 ml volume were collected. Thin layer
chromatographic analysis at this point (l00~ ethyl acetate)
determined the presence of ultra violet visible excess
reagent in the earlier fractions with the later fractions
containing an unknown mixture. All fractions were recom
bined and rechromatographed over 200g Florisil in 20:80
ethyl acetate/skelly solvent B and 0.25~ triethyleneamine.
The column was eluted with 250 ml of 20:80, 30:70, 40:60,
and 50:50 ethyl acetate/skelly solvent B and 0.25~
triethyleneamine. Thin layer chromatographic analysis in
50:50 ethyl acetate/hexane showed that fractions 2-5
contained excess reagent, fractions 9-11, 0.l0g of a clearly
less polar substance, and fractions 17-21, the product,
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(O.lOg, 0.000]~74 moles, (23k)): mass spectrum - last ion
of any significant intensity at (m/e) 684; ir (CCl~.) 3400 cm~
~0I~;Anai: Calcd. for C42H62Si2O6: 718.4085. Found 718.4037.
Synthesis of 6-alpha and 6-beta-l646-Dimethyl PolL
Isomers via Mercuration of l6J6-Dimethvl-P~F9-alpha (XLVII
and XLVIII).--A 500 ml, 3-necked flask was charged with 3.6g
of mercuric acetate and 30 ml of water. The mixture was
stirred until the mercuric acetate dissolved and then treated
with 20 ml tetrahydrofuran. A solution of 2.Og of 16,16-
dimethyl PGF2-alpha (XL) in 40 ml tetrahydrofuran was then
added and the mixture stirred for 2 hr at room temperature.
A solution of 0.75g of sodium borohydride in 30 ml of lN
sodium hydroxide solution was added in portions over 5 mm
under a nitrogen atmosphere. After stirring for an additional
20 mm the mixture was acidified with dilute hydrochloric
acid. Ether (100 ml) was added, then sodium chloride to
saturation. The organic phase was separated. The aqueous
layer which contained droplets of free mercury was extracted
twice more with ether. The combined ether extracts were
washed with brine, dried over magnesium sulfate and
evaporated to afford 2.49g of oil. Thin layer chromatography
(ethyl acetate:cyclohexane:acetic acid - 40:60:2) indicated
3 close spots. The major spot was in the center. The more
polar minor spot appeared to be unreacted starting material.
Multiple attempts to separate the mixture via chromatography
over standard CC-4 silica gel using both methylene chloride/
21
acetone and ethyl acetate/skelly solvent B systems gave only
marginal success. Ultimately, best results were obtained
using high pressure liquid chromatography over a 141g
acid-washed silica gel column eluting with 20-5O~ acetone
in methylene chloride. This afforded O.24g of the tic-
homogeneous 6-alpha isomer (Rf-0.36 in 60:40:2) and 0.58g
of 6-beta isomer (Rf-O.33 in A-IX system).
Synthesis of 6-Keto-16,l6-Dimethyl P~F~-alpha Methyl
Ester (LI).--A solution of 2.29g (6.Q m mol) of the ether
(XLIII) in 100 ml of ether and 25 ml of tetrahydrofuran
was treated with 25 ml of 5~ hydrochloric acid and stirred
for 20 minutes. The organic layer was separated and the
aqueous layer was washed once with ether. The combined
ether extracts were washed twice with brine, dried over
magnesium sulfate, filtered and evaporated. This resulted
in a crude weight of 2.70g. The yellow residue was
chromatographed over lOOg of silica gel and eluted with
250 ml of 40:60 ethyl acetate/skelly solvent B, 500 ml
of 80:20 ethyl acetate/skelly solvent B and 1500 ml of 100~
ethyl acetate, Fractions 21-25 ((A)-0.80g) and fractions
26-77 ((B)-l.07g) were combined. Fraction A was rechroma
tographed over 50g silica gel using the same elutants to
give more material like cut B. The overall yield was
1•77g (74~). Anal: Calcd. for C34H70Si4N06: 700.4280. Found:
(for M±C1j3 of methoxime TMS derivative) 700.4307.
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Synthesis of 1l,l5-Bis-Tetrahydropyranyl Ether of
6-Keto-l6, l6-Dimethyl-P~,F~ -alpha Methyl Ester (LII) . --
A mixture of l.77g (4.3 ~m mol) of 6-keto-l6,l6-dimethyl
PGF1-alpha methyl ester (LI), 25 ml methylene chloride,
3.5 ml dihydropyran, and 1.5 ml pyridine hydrochloric acid
in methylene chloride solution was stirred at room tempera
ture for 24 hr. Thin layer chromatographic analysis using
50:50 ethyl acetate/cyclohexane demonstrated the completion
of the reaction. The mixture was then transferred to a
separatory funnel with a small amount of methylene chloride.
The organic layer was washed once with saturated sodium
carbonate solution, twice with brine, dried over magnesium
sulfate and evaporated. The yellow residue was chromato
graphed over 50g of silica gel using 500 ml of 10:90 and
25:75 acetone/methylene chloride as elutants. The combination
of appropriate fractions on the basis of thin layer chroma
tographic results using 33:67 ethyl acetate/cyclohexane
afforded 1.86g of a less polar substance and 0.48g of a more
polar substance. The less polar substance was rechromato
graphed using slurry of 50g silica gel made up with l007~
methylene chloride. The column was eluted with 300 ml lOOt
methylene chloride, 750 ml 5:95 acetone/methylene chloride
and 500 ml 20:80 acetone/methylene chloride. By thin layer•
chromatographic analysis in 33:67 ethyl acetate/cyclohexane,
it was determined that an additional l.llg contained product.
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These fractions (total of l.59g) were shown to be
contaminated by thin layer chromatography, but this is
typical behavior for a 6-keto-P0F1-alpha methyl ester
structure.
Syn the s is ofthel~l5-Bis-T~ydro’~anlEtiier
of 6-Keto-l6,l6-Dimethy]~~Q~j (LIV).--A mixture of l.59g
(2.8m mol) of the crude ester, 35 ml methanol and 10 ml 3N
sodium hydroxide was stirred at room temperature for 4 hours
under nitrogen. After cooling in an ice-bath, solid sodium
chloride and potassium hydrogen sulfate solution were added
to saturate and acidify the solution respectively. The
solution was then extracted twice with ethyl acetate. The
combined extracts were washed with brine, dried over magnesium
sulfate, and evaporated. Thin layer chromatographic analysis
(A-IX) at this point demonstrated completion of the reaction.
An 89~ yield of a yellow oil was obtained. With stirring in
a methanol-ice bath, a solution of l.39g of the yellow oil in
50 ml acetone was treated dropwise with 3.5 ml of Jones’
reagent over a 5 minute period. The mixture was stirred in
a cooling bath for an additional 30 minutes. Thin layer
chromatographic analysis in 60:40:2 demonstrated the
completion of the reaction. Isopropanol (10 ml) was added
to this solution and the reaction mixture was stirred for
10 minutes. The reaction mixture was then concentrated to
one-fourth of its volume, extracted three times with ether,
washed once with brine, and evaporated. A yellow oil (l.29g)
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was chromatographed over 150g of CC-4 silica gel made up with
l00~ methylene chloride. The column was eluted with 250 ml
of methylene chloride, I liter of both 5:95 and 10:90 acet~ne/
methylene chloride, and 500 ml 25:75 acetone/methylene
chloride. Fractions of 50 ml volume were collected. Thin
layer chromatographic analysis at this point in 40:60:2
showed considerable contamination, but fractions 6-8 (A)
(0.06g), fractions 9-11 (B) (0.05g) and fractions 12-47 (C)
(0.90g) were obtained. Fraction C was determined to contain
the desired product (58~ yield)
Synthesis of 6-Keto-l6,l6-Dimet~ P1E1 (LV).--With
swirling, bis-tetrahydropyranyl ether (0.90g) (LIV) was
dissolved in 10 ml acetic acid, 4 ml water and warmed at
40-45° for 4 hr. Thin layer chromatographic analysis in
A-IX demonstrated the completion of the reaction. The solu
tion was then diluted with brine, and extracted three times
with 25 ml portions of chloroform. The combined organic
layers were then washed twice with brine, dried over magnesium
sulfate and evaporated at 40-45° to dryness. The yellow
residue was chrornatographed over a column made up with .5Og
CC-4 silica gel in 25:75 ethyl acetate/skelly solvent B.
Additional elutions were made with250 ml of 25:75 ethyl
acetate/skelly solvent B. Fractions of 50 ml volume were
collected. The combination of fractions on the basis of thin
layer chromatographic results using A-IX afforded 0.2lg
(33~ yield) of the desired product. The appearance of an
25
ultraviolet-visible by-product as seen in previous analogs
was not evident: mass spectrum (n/c) 612 (weak), and other
very weak ions at 522, 513; uv max (957~ C2H5OH) 278 nrc,
trace at 378 nm. -
RESULTS AND DISCUSSION
The sequence used is sho~ in Scheme Iv~8 The reaction
of l6,l6-dimethyl P0F2-alpha (XL), with methyl iodide resulted
in a 68~ yield of the corresponding methyl ester (XLI). The
methyl ester (XLI) was identified by mass spectometry, infra
red, and mainly by a singlet in the nmr at c~3.7 ppm. lodination
of 16,16-dimethyl P0F1-~lp]~a methyl ester (XLI) afforded
5-iodo-6,-R,S,-16,l6-dimethyl P011 methyl -ester (XLII) in
nearly quantitative yield. XLII was identified by the
appearance of a strong ion at (m/e) 651. No effort was made
to separate the isomers. Deiodination of (XLII) with tn
butyl tin hydride prepared in situ from tri-butyl tin chlo
ride and sodium borohydride gave the dominant 6-beta-POll
methyl ester (XLV) in 33~ yield. (XLV) was identified by a
weak N+ at 540 in the mass spectrum. Hydrolysis with 3N
sodium hydroxide produced the corresponding free acid,
l6,l6-dimethyl, ~G1l (XLVIII), which had been previously
prepared. ~
Dehydrohalogenation of the iodo-ether (XLII) with 1.5
diazabicyclo [4.3.01 non-5-ene (DBN) gave crude 16,16-
dimethyl P012 methyl ester (XLIII) in 88k yield. The nmr
spectrum, (CDC13) ~5.53 (multiplet), a4.67 (multiplet),
~4.32 (multiplet), and a 3.67 (singlet) was mainly used
to identify this compound. An organic base, 1,5 diaza
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most versatile dehydrohalogenatizzg agent known. DBN is
made readily and is available commercially. It is a strong
proton abstractor and its cation probably forms an un
usually stable ion pair with the leaving halide group.
The previously mentioned methyl ester (XLIII) without
purification was converted to the more stable salt by
hydrolysis with sodium bicarbonate in aqueous methanol. A
p-phenyl phenacyl ester assay was used for the identiflca
tion of the sodium salt. The salt did not crystallize as
does ~G12 sodium salt, therefore the product was frozen
and lypholized to afford a 3fl yield as a hygroscopic white
foam. Treatment of the salt with p-phenyl phenacyl bromide
in dimethyl formamide gave the p-phenyl phenacyl ester of
16,16-dimethyl PGI2 (L) in a 231 yield. The mass spectrum
showed the last ion of any significant intensity at (m/e)
684. The material exhibited the correct tlc mobility when
freshly prepared, but on standing, rapidly decomposed to the
stable 6-keto PGF1-alpha derivative. Hydrolysis of the
sodium salt under acidic conditions (101 HC1) gave 6-keto
16,l6-dimethyl PGF1-alpha (XLIX) in 771 yield. Thin layer
chromatography (A-IX) showed an Rf of 0.15.
The sequence of iodination, dehydroiodination and
hydrolysis were repeated to produce the 6-keto 16,16-
dimethyl PGF1-alpha methyl ester (LI). The reaction of a
mixture of 6-keto 16,16-dimethyl PGF1-*).pha methyl ester
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(LI) with dihydropyran and pyridine HC1 in methylene
chloride solution resulted in positions 11 and 15 being
protected as tetrahydropyrany]. ethers. Subjecting the
corresponding free acid (LIII) to Jones’ oxidation by
dropwise treatment with Jones’ reagent over a 5 minute
period and removing the protective groups afforded
6-keto 16,16-dimethyl PGE1 (LV).
All 16 16-dimethyl analogs reported were obtained
as oils.
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